J.P. Azulay

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Ralf Reilmann, Andrew McGarry, Igor D. Grachev et al. · The Lancet Neurology · 2018 · 104 citations

Neurodegenerative Diseases, Medicine, Psychotropic Medication +6

Myopathy with lobulated muscle fibers: evidence for heterogeneous etiology and clinical presentation

Dominique Figarella‐Branger, M. El-Dassouki, Amets Sáenz et al. · Neuromuscular Disorders · 2002 · 31 citations

Mitochondrial Myopathy, Mechanobiology, Kinesiology +12

Emery-Dreifuss muscular dystrophy: linkage to markers in distal Xq28.

John R.W. Yates, Jon Warner, Julian A. Smith et al. · Journal of Medical Genetics · 1993 · 26 citations · Full text

Distal Xq28, Genetics, Genetic Epidemiology +21

Regression of Allopurinol-lnduced Peripheral Neuropathy after Drug Withdrawal

J.P. Azulay, Olivier Blin, Patricia Valentin et al. · European Neurology · 1993 · 15 citations

Allopurinol-lnduced Peripheral Neuropathy, Peripheral Nerve Injury, Pain Medicine +17

[Late-onset multiple sclerosis and serum monoclonal gammopathy: an incidental association?].

Sylvie Tréfouret, J.P. Azulay, Jean‐Pierre Pouget et al. · PubMed · 1997 · 11 citations